GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » 3-Year EPS without NRI Growth Rate

Spago Nanomedical AB (OSTO:SPAGO) 3-Year EPS without NRI Growth Rate : 51.20% (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB 3-Year EPS without NRI Growth Rate?

Spago Nanomedical AB's EPS without NRI for the three months ended in Dec. 2024 was kr-0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 51.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Spago Nanomedical AB was 51.20% per year. The lowest was -14.30% per year. And the median was 13.30% per year.


Competitive Comparison of Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate falls into.


;
;

Spago Nanomedical AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Spago Nanomedical AB  (OSTO:SPAGO) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Spago Nanomedical AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines